InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Hendrix Martin. Director active across 1 company, notably Prometheus Biosciences, Inc.. Aggregated, 2 reports have been published. History available since 19 May 2023. The latest transaction was disclosed on 19 May 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations